RCEL

AVITA Medical (RCEL)

About AVITA Medical (RCEL)

AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.

Details

Daily high
$4.73
Daily low
$4.29
Price at open
$4.61
52 Week High
$10.29
52 Week Low
$3.22
Market cap
113.8M
Dividend yield
0.00%
Volume
208,739
Avg. volume
241,515
P/E ratio
-2.62

AVITA Medical News

Details

Daily high
$4.73
Daily low
$4.29
Price at open
$4.61
52 Week High
$10.29
52 Week Low
$3.22
Market cap
113.8M
Dividend yield
0.00%
Volume
208,739
Avg. volume
241,515
P/E ratio
-2.62